Www data SE

Logitech G-Series Keyboards

2014.01.15 21:34 SeanTheLawn Logitech G-Series Keyboards

A subreddit dedicated to news and apps for the Logitech G19, G15, G510 and G13 keyboards!
[link]


2013.02.12 22:00 PinkBlowCream Norrlands Athen, Öbacka och Staden bakom flötet

En gemenskap för och om staden Härnösand.
[link]


2015.01.16 02:06 oakgrove Atlanta Weather

Upcoming weather alerts, weather analysis and discussion for the Atlanta area.
[link]


2020.12.05 12:11 wigi1 infj see wigi graphic of your thought process and thought spin. infj how it logically works .. wigi is sure of it ..

check that https://www.wykop.pl/cdn/c3201142/comment_1607165997JdK1okxN3NRoGP4Z0qNQSz.jpg
-this is how Ni works and inverts the mirror image then Ti reflects the image horizontally and compares it with Ni .. like looking in a car forward and comparing it with the image of a mirror with I will write a mirror "ambulance"
The wigi model is based on comparing these functions with entp, which are very similar and inverse, logical and easier.
prior data .. https://www.reddit.com/entp/comments/k0wrpwigi_has_something_really_weird_about_infj_vs/
ps. does it help infj?
submitted by wigi1 to infj [link] [comments]


2020.12.05 02:44 Markus1990 December Variety Star Brand Reputation Rankings Announced

The Korean Business Research Institute has published this month’s brand reputation rankings for variety stars!
The rankings were determined through an analysis of the consumer participation, media coverage, interaction, and community awareness indexes of 50 popular entertainers, using big data collected from November 5 to December 5.
Yoo Jae Suk held onto his spot at the top of the list this month with a brand reputation index of 1,712,309 for December. High-ranking phrases in his keyword analysis included “You Quiz,” “Gong Yoo,” and “alter ego,” while his highest-ranking related terms included “appear,” “advertise,” and “transform.” Yoo Jae Suk’s positivity-negativity analysis revealed a score of 85.50 percent percent positive reactions.
Kang Ho Dong similarly maintained his position at second place in the rankings with a brand reputation index of 1,065,669 for the month.
Finally, Kim Gura came in at a close third with a brand reputation index of 956,033, marking a 48.76 percent increase in his score since November.
Check out the top 30 for this month below!
  1. Yoo Jae Suk
  2. Kang Ho Dong
  3. Kim Gura
  4. Kim Jong Min
  5. Ahn Jung Hwan
  6. Park Na Rae
  7. HaHa
  8. Kim Jong Kook
  9. Seo Jang Hoon
  10. Choi Yang Rak
  11. Kim Sung Joo
  12. Paeng Hyun Sook
  13. Jang Do Yeon
  14. Lee Kyung Kyu
  15. Lee Soo Geun
  16. Shin Dong Yup
  17. Super Junior’s Kim Heechul
  18. Park Mi Sun
  19. Jo Se Ho
  20. Moon Se Yoon
  21. Lee Kwang Soo
  22. Jun Hyun Moo
  23. Lee Young Ja
  24. Park Myung Soo
  25. Song Hae
  26. Lee Hyori
  27. Cha Tae Hyun
  28. Ahn Young Mi
  29. Kim Joon Hyun
  30. Yoo Hee Yeol
Source: https://www.soompi.com/article/1441741wpp/december-variety-star-brand-reputation-rankings-announced-2
submitted by Markus1990 to koreanvariety [link] [comments]


2020.12.05 02:02 LilahDice Plicul NU A AJUNS; despre niște oameni

Acesta este un text scris din perspectivă subiectivă.
Am văzut postări și comentarii îngrijorătoare despre cum multe voturi prin corespondență nu au fost livrate, și nu doar dintr-o țară sau două. La un moment dat cineva a insinuat că e mânărie, iar OP a răspuns că cel mai probabil e doar incompetența Poștei Române. Dar my „mânărie” senses were tingling și mi-am spus hmm, hai să cercetăm să vedem cine e în spate. (Și de la asta am ajuns la o serie de informații cu care nu știu ce să fac, așa că le pun aici.)
Disclaimer: Eu nu susțin că e ocultă național-mondială sau schemă orchestrată de PNL (deși bat apropo-uri, recunosc). Nu dovedesc nimic până la urmă. Doar consider că oamenii din spatele lucrurilor contează, iar cei cu funcții de conducere și mai mult. Așa că am întrebat internetul despre una-alta și am selectat informații care mi-au stârnit interesul.
Contextul este cel pe care îl știm: Alegeri Parlamentare 2020.
Începem cu prim-incompetenții: Poșta Română (well, Compania Națională Poşta Română S.A.). Este operatorul naţional din domeniul serviciilor poştale şi se află în proprietatea statului român, reprezentat de Ministerul Transporturilor, Infrastructurii şi Comunicaţiilor (93,52% din pachetul de acţiuni). Restul de acțiuni sunt la Fondul Proprietatea, administrată de Franklin Resources, Inc. Sunt mulți americani printre reprezentanții permanenți, iar singurul român e un flăcău care pune video-uri cu Mândruță pe Facebook în 1970. I SHIT YOU NOT! 19fking70.
Ministerul Transportului? Lucian Nicolae Bode, om fidel PNL/PD. Are experiență în treburi guvernamentale că a mai fost Ministrul Economiei, Comerţului şi Mediului de Afaceri în 2012, în Guvernul Ponta. În rest, e un om fad. No drama, nu transmite nimic.
Revenim la conducerea Poștei Române, o eternă dramă românească. Îl avem Director General provizoriu pe Horia Grigorescu, un tânăr de aproape 30 de ani care s-a născut în data de 21 septembrie 1988. Pesemne că nu și-a actualizat blogul, pentru că eu am luat aproape mot-a-mot de pe site-ul lui. Vă rog să verificați, mai ales că el expune acolo gânduri, idealuri și îndemne la CURAJ! Este un exemplu de succes, avocat, a ajuns Secretar General al PNL Sector 4, plimbat pe la TV-uri, arată bine.
Pe lângă Grigorescu (sau sub el) mai sunt două persoane:
Un Director General Adjunct este un domn pe care internetul nu îl cunoaște dincolo de CV-ul luisemi-completat, din care reiese că a trăit o viață în SUA. În orice caz, sper să nu fie acest Florin-Valentin Ștefan care posta despre o petiție în care i se cerea lui Mândruță să intre în politică. Mândruță strikes twice, deja văd pattern.
Celălalt Director Adjunct este o fire dinamică, so she says. Mi s-a părut că găsesc potential dramatic în faptul că doamna Alecu e din Constanța, ca șeful (oh!), și că au terminat același liceu (ooh!), dar exageram. Îi despart vreo 15 ani, cam tot de cât timp lucrează doamna la poștă. În timpul liber este și ea fan PNL.
Lăsăm Poșta Română deoparte acum, pentru că alegerile sunt organizate și supravegheate de Autoritatea Electorală Permanentă - cei care au trimis mail că plicul NU A AJUNS și au închieiat cu „Vă mulțumim că ați ales să votați prin corespondență!” (???).
Președintele de aici e Constantin-Florin Mituleţu-Buică. Are un nume stupid și lung, ceea ce e mereu util când faci pe stalker-ul, că îi găsești ușor. Partea proastă e că omul are COVID, ceea ce înseamnă că e plin google cu această știre. Asta mă duce pe conspirație puțin și mă gândesc că e o metodă bună să te distragi atenția, că nu prea te caută lumea dincolo de prima pagină. Dar eu am dat și pe a treia pagină chiar și am aflat că e acuzat de PressOne că a plagiat, iar alții zic că ar fi furat. Deci nimic ieșit din comun până acum. Mituleţu-Buică e președinte de aproape doi ani, iar înainte de asta a fost tot în funcții înalte pe acolo. Doar prin anul 2014 mai e ceva interesant, că era Ministru Delegat pentru Dialog Social. Un ultim aspect din viața domnului Mitulețu-Buică este că nevasta Tatiana e Consilier Parlamentar la Camera Deputaților – Cabinet Secretar General de vreo trei ani. Dar am adăugat asta numai pentru elementul dramatic, nu spun că înseamnă ceva.

Am recitit tot ce am scris și recunosc că m-a plictisit... Dar dacă tot am scris atât, am postat.
Un lucru știu! Duminică merg la vot, cel puțin ca să pot să mă plâng de ei încă 4 ani!

TLDR: Sunt destule discuții despre plicuri cu voturi care nu ajung; unii zic că e schemă, eu m-am întrebat de ce ar fi și cine ar fi în spatele ei, apoi am căutat informații despre oameni. Nu am aflat nimic anume. Hai la vot!
submitted by LilahDice to Romania [link] [comments]


2020.12.04 18:18 correvedileivuelve Desblanqueando al bolivarianismo. «Informe especial Las sanciones económicas contra Venezuela: consecuencias, crisis humanitaria, alternativas y acuerdo humanitario» (Manuel Sutherland, economista marxista)

Se trata de un resumen basado a su vez en un informe en "versión resumida" (pdf de 78 páginas que se encuentra al final de la página enlazada) realizado por Manuel Sutherland para Provea, Programa Venezolano de Educación-Acción en Derechos Humanos, del que voy a citar algunos fragmentos.
»[...] Venezuela atraviesa la peor crisis económica que ha sufrido la nación en su historia, de lejos. La crisis actual es la más drástica en la historia de América y es considerada (hasta 2019) como la novena más fuerte a nivel mundial en los últimos setenta años. La explosión de la crisis (primer trimestre de 2014) es muy anterior a las primeras sanciones financieras de agosto de 2017 y a las sanciones económicas y petroleras de mayor calado: noviembre de 2018. Por ende, todo parece indicar que las sanciones son posteriores a la crisis y que sólo agudizan, inexorablemente, un ciclo económico con una muy marcada tendencia recesiva.
»A pesar de lo anteriormente comentado, es menester indagar en las consecuencias directas que las sanciones imponen en la economía, es decir, en el proceso nacional de acumulación de capital (Iñigo, 2008) y como éste determina un devenir social que deriva en una emergencia humanitaria compleja, que ha hecho imposible la satisfacción de las necesidades humanas más básicas, a millones de personas. Es decir, medir el impacto en los derechos humanos universales relacionados con la economía, que la crisis y las sanciones imponen en una nación entera.
 
Crónica de una muerte anunciada: el Híper rentismo bolivariano y el derroche
»El híper rentismo bolivariano, que nada tiene que ver con las sanciones, estalla justo cuando la renta se encuentra en pleno apogeo. Es un problema de sobre abundancia de ingresos que devienen de un incremento de precios que no pasa por un aumento en la cantidad de productos elaborados y vendidos. Por ello, se lo considera como una especie de provento, un ingreso adicional a la economía que es generado en otras latitudes, centros industriales, y que es transferido a los capitales que trabajan en condiciones naturales ventajosas, donde el trabajo se hace más productivo sólo por un aumento vertiginoso del precio y una demanda que debe comprar esa mercancía, en las tierras menos “rendidoras”, donde el trabajo es mucho menos eficiente (Marx). [...] Desgraciadamente, el chavismo se hundió en la ciénaga del rentismo, lo hipertrofió con políticas que fungieron como efectivos esteroides. Cuando cayera el precio del petróleo, o disminuyera la extracción de crudo, iba a venir la debacle, era completamente inevitable si los recursos no se ahorraban escrupulosamente.
»La sobrevaluación del tipo de cambio crea un país ficticio en el que la economía luce mucho más fuerte de lo que en verdad es, al equiparar la productividad del sector petrolero con otros fragmentos de capital mucho menos eficientes. Ello ofrece un poder de compra mucho más grande que el agregado que devendría de la productividad de cada factor económico no petrolero. Ello deriva en una disminución de los precios artificial de las mercancías importadas y en el ineludible destruir de la frágil competitividad de las empresas locales. Cuando la renta cae estrepitosamente, no hay divisas para importar y se sobreviene un fuerte ajuste cambiario que trae inflación y una maciza fuga de capitales que agudizan el ciclo recesivo de la economía. Eso trae consigo el agravante, que la producción interna ha sido devastada por la inserción rentística del provento petrolero, por ello los problemas recesivos de la crisis se multiplican.
»La gestión bolivariana de la renta agudizó todos los procesos anteriormente descritos y que ya habían sucedido en nuestro país. La nefanda sobrevaluación extrema fue impulsada por la tríada: control cambiario con asignación de divisas a discreción, congelamiento de tasas de interés y emisión de dinero suplementario de manera excesiva. Todo ello aunado a una hipertrofia estatal que elevó a las importaciones públicas en más de mil por ciento (2003-2012) y que tejió una red clientelar de corrupción sin límites que literalmente lumpenizó a la economía. Todo ello tenía que terminar muy mal, el colapso debía ocurrir en proporción a los horrores económicos cometidos. El estallido de la crisis fue, y debía darse con o sin sanciones, absolutamente inevitable.
 
Las sanciones y sus consecuencias económicas inmediatas
»[...] Las sanciones económicas arrancan a finales del año 2018 y las sanciones directamente petroleras dirigidas a la producción (sin dudas las más fuertes y destructivas de todas) apenas se han estructurado en enero de 2019, además de contar con “Licencias Generales” emitidas por el DTE, que ofrecían ciertas excepciones para hacer negocios, hasta finales de abril o mediados de julio de 2019.
»[...] El hecho de que la importación de comida y alimentos en 2018 sólo haya sido de 2600 millones de dólares (Weisbrot & Sachs, 2019), cuando en 2012 llegó a ser 8 veces más (Instituto Nacional de Estadísticas (INE)), no es causado por las “sanciones”, sino por la crisis de economía capitalista centrada en el rentismo petrolero.
»[...] El asunto es que la gravedad de los problemas económicos ha alejado a los prestamistas internacionales que desde 2016 ven imposible que Venezuela pueda cancelar sus acreencias. Así las cosas, desde hace cerca de cinco años que el Banco de Desarrollo Chino no le presta más dinero a Venezuela. El gigante: Banco de Asia, tampoco suministra ni abre líneas de créditos al país, incluso teniendo enormes cantidades de dinero sobrante. [...] Por ende, China no le sigue proporcionando recursos financieros a Venezuela no por las sanciones, sino por el desastroso estado de la economía y la muy fuerte inseguridad jurídica, que hace prácticamente inviable la devolución de cualquier empréstito, incluso si se tiene un acuerdo para ser pagado con el mismo petróleo que las empresas chinas extraen en Venezuela.
El “embargo” de CITGO es gravísimo, pero no es la causa de la caída en la producción de petróleo, como de alguna manera muy poco formal, aseveran los insignes (Weisbrot & Sachs, 2019). Si bien CITGO llegó a comercializar hasta 580 mil barriles diarios con PDVSA, en tiempos relativamente recientes, las cantidades que PDVSA ya no podría enviar a CITGO se pueden colocar en otros mercados, y los diluentes y el petróleo liviano, también se pueden adquirir en otros espacios, aunque a un precio mucho mayor, lo que reduce severamente el beneficio. Lo anterior no puede justificar la caída de alrededor del 70 % (2008-2019) en la producción petrolera. Tan feroz derrumbe se puede apreciar como un tobogán que arranca tan temprano como en el 2009 (Hausmann & Muci, 2019) casi 9 años antes de las primeras sanciones petroleras. De hecho, ya en 2016 y según (Atlas Económico, s.f.) la exportación de petróleo crudo ya había caído en un imponente 68 %, con respecto a 2012.
»La caída en la producción petrolera tiene múltiples factores por completo ajenos a las medidas de reciente data contra PDVSA. Podría decirse que la exigua inversión efectiva, la venta de divisas que le ingresan por exportación a un precio bastante disminuido, la escasez de fuerza de trabajo calificada por los bajísimos salarios, la enorme corrupción en los manejos de la empresa, el irrisorio ingreso interno al regalar la gasolina, expropiaciones y problemas con transnacionales contratistas y el endeudamiento exagerado para captar divisas que posteriormente eran regaladas en el mercado interno a un precio microscópico, son los elementos constitutivos de una destrucción empresarial sin precedentes.
 
El subsidio de la gasolina es decisivo en la ruina de la empresa
»[...] la venta al público de la gasolina en Venezuela por un precio ínfimo, genera pérdidas de alrededor de 12.000 millones de dólares anuales: » (…) tomando en cuenta los costos reales que tiene la industria petrolera por la producción de la gasolina para abastecer el mercado interno» (EFE, 2020). Esta escandalosa cantidad que equivale a más de un cuarto del PIB de Bolivia en 2020, pudiera ser aún más elevada, si se consideran los costos de oportunidad, es decir, lo que PDVSA deja de percibir en el mercado internacional por esa misma gasolina.
 
La no disponibilidad de medicinas no se debe a las sanciones
»[...] ¿Por qué Venezuela no produce por sí misma sus alimentos y medicinas? ¿Por qué no usaron parte del trillón, si, un millón de millones de dólares que ingresaron entre 1999 y 2015, para construir una industria farmacéutica estatal? En vez de ello el gobierno prefirió aumentar la importación de fármacos de manera indiscriminada, porque el negocio de la importación era apropiarse con base a fraudes de divisas “preferenciales” mucho más baratas que en el mercado paralelo.
»[...] “(…) al cierre de 2018, cuando todavía no habían entrado en vigor las medidas más relevantes, las importaciones de medicamentos habían caído 96 % en relación con 2012 y las de alimentos más de 70%. (…) El efecto económico de las medidas, en relación a la catástrofe que engendró el chavismo, es relativamente marginal, y en cualquier caso bastante menor de lo que muchos analistas interesados han querido hacer ver. (…) para mí está claro que entre el 80% y 90% del deterioro generalizado que estamos padeciendo se había producido ya antes de las sanciones.” (Santos M. A., 2020)
»[...] El colapso del sistema eléctrico y los durísimos racionamientos devienen de una serie de grotescos subsidios que han arruinado a las empresas estatales que, al dispensar sus servicios con tarifas ínfimas, ya no pueden recuperar lo que requieren para invertir en mantenimiento e infraestructura. Literalmente, el servicio eléctrico lleva años regalándose. La tarifa de varios apartamentos no alcanza a un solo dólar mensual (sumados). Ni hablar de que la gran compañía estatal CADAFE pierde alrededor del 40% de su electricidad (energía no facturada) por sostenidos robos en conexiones ilegales. Se estima que los subsidios totales entregados por concepto energético entre 2014 y 2016 alcanzaron los 75.000 millones de dólares, alrededor de 10 veces la deuda externa de Bolivia en 2016. Vistos de forma acumulada, esa cifra podría equivaler a cerca de dos veces el PIB promedio real del año 2020. Esto es evidentemente insostenible y una invitación a la dilapidación. El gasto estatal en educación, salud y vivienda (sumados) apenas alcanzó en 2013 el 9,6 % del PIB, muy por debajo del subsidio energético otorgado (Sutherland, Venezuela y el colapso eléctrico, 2019).
 
Las sanciones son nocivas a la economía, pero no causaron la crisis
»[...] la imposibilidad de reestructurar la deuda no es culpa de las sanciones sino del devenir desastroso de la economía. Según la firma: Ecoanalítica, el monto global del atraso en los pagos de la deuda venezolana a 2019, alcanza la suma de 18 mil millones de dólares (Salmerón, 2020), sin incluir deudas a proveedores y otros empréstitos.
 
Liquidez monetaria o la destrucción progresiva del bolívar
»[...] en 2011 la liquidez equivalía a 47 mil millones de dólares y que para el año de 2017 dicho saldo era apenas de 1.143 millones de dólares. Estamos hablando de una caída de 97,5 % en la cantidad de dinero en manos de todos los venezolanos, incluyendo al ámbito estatal y al sector privado. Ello evidencia una destrucción económica sin precedentes, en la cual la población carece por completo de los medios de pagos mínimos para realizar en el mercado las operaciones que permitan la circulación de mercancías que de la producción deriva. De nuevo, ello ocurre antes de la primera sanción financiera. Si medimos la liquidez monetaria (LM) per cápita, nos damos cuenta que sólo tenemos 15 dólares por habitante (2020), una cifra impresionantemente microscópica. Es interesante saber que en Panamá la LM en dólares de EEUU ($), per cápita, alcanza los: $ 6.443. En Trinidad y Tobago llega a: $ 11.243, en Chile: $ 7.356, en Ecuador: $ 3.154 y en Haití hay: $ 372.
 
Liquidez monetaria per cápita como indicador de la desaparición del dinero
»[...] Venezuela lleva al menos desde 2013 con severos problemas de disponibilidad de efectivo, que ya para finales de 2015 se constituía una gravísima crisis. El tipo de cambio se había disparado y la inflación llevaba años haciendo estragos. De manera dolorosa, muchos vimos como en ese 2015 las personas llevaban dinero venezolano en carretillas y bolsos. En Cúcuta, la zona fronteriza con Colombia, los bolívares se cambiaban por su peso, ya que la magnitud de dinero que se requería para comprar apenas 100 dólares rozaba los Bs. 91.000. Teniendo en cuenta que el billete de más alta denominación era el de Bs. 100, se necesitaban 910 billetes para comprar: $ 100, unos 900 gramos aproximadamente. La escasez de efectivo era ya muy fuerte, poco a poco el dinero perdía todo su valor y sus tres facultades esenciales: reserva de valor, medio de pago y unidad de cuenta.
»[...] En 2009 había un equivalente de bolívares, en monedas y billetes, de 173 dólares por habitante. Para agosto de 2017 apenas había 2 dólares per cápita, ello representa una caída de 98,8 % en la cantidad de monedas y billetes que circulan en la economía. Esta destrucción del bolívar es muy previa a las sanciones y nos muestra la potencia de una crisis rentística de enorme magnitud.
[...]
 
Consideraciones finales
https://www.derechos.org.ve/actualidad/informe-especial-las-sanciones-economicas-contra-venezuela-consecuencias-crisis-humanitaria-alternativas-y-acuerdo-humanitario
 
[¡¡ Aleeee !!, qué a gusto me he quedado con el resumido resumen de la versión resumida. Ahora vais y lo cascáis, que yo... ya corrí a decíroslo y estoy de vuelta, jijijijijiji...]
submitted by correvedileivuelve to Gulag_Podemos [link] [comments]


2020.12.04 17:41 swati_1510 Keystone Aftermarket Wheels Market: Potential Effect on Upcoming Future Growth, Competitive Analysis and Forecast 2027

The current report on the Keystone Aftermarket Wheels Market provides a comprehensive assessment of the business vertical and offers a comprehensive overview of the industry along with its key segments. The study includes an accurate estimate of the current industry scenario along with the market size, market volume, and revenue garnered by the industry. The report delivers radical data about the competitive landscape of the Keystone Aftermarket Wheels industry and a thorough bifurcation of the regions where the Keystone Aftermarket Wheels market has established a significant footing. The report further estimates the market scenario in context with the COVID-19 pandemic. The report analyses the current market scenario along with the effects of the COVID-19 on the present and future scenario. The report also focuses on the key changes, progress, or hurdles due to the COVID-19 pandemic.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1681
Key Summary of Regional Analysis and Competitive Landscape:
The report offers a comprehensive overview of the competitive landscape of the Keystone Aftermarket Wheels industry. The competitive landscape includes extensive profiling and overview of prominent players of the Keystone Aftermarket Wheels industry. The report studies the following companies in detail: Royal Dutch Shell Plc, LyondellBasell Industries Holdings B.V, China Petroleum and Chemical Corporation, BASF SE, SK Global Chemical Co., Ltd, China National Petroleum Corporation, Reliance Industries Limited, ExxonMobil Corporation, Chinese Petroleum Corporation.
Radical Highlights of the Keystone Aftermarket Wheels Market Report:
The research report provides an accurate analysis of the product range, application spectrum, regional analysis, and competitive landscape of the Keystone Aftermarket Wheels industry.
The market is categorized on the basis of the types into
Toluene
Xylene
Ethylbenzene solvent
Based on application, the Keystone Aftermarket Wheels market is segmented into
Cleaning and Degreasing
Printing Inks
Adhesives
Paints and coatings
Others.
The report offers key details about the production volume and price analysis.
Moreover, it also offers radical information about growth prospects and patterns. It also provides extensive coverage of the product consumption of each application and product. The report also provides a pricing analysis and growth trends for the key segments of the market.
To know more about the report, click @ https://www.reportsanddata.com/report-detail/aromatic-solvents-market
Along with the basic information, the report also offers insights into marketing strategies readily adopted by the key manufacturers for the endorsement of their products. The report offers significant data pertaining to development trends and market position to offer deeper insights into targeted clients, brand promotions, and pricing analysis. The report also sheds light on the supply chains and the changes in the trends of the upstream raw materials and downstream distributors.
The report explains the market share and sales volume of each company, along with the key details of the operations of these companies. The report further offers extensive coverage of their product portfolio, business expansion plans, gross profit margins, revenue contribution, investment plans, and financial standings. The report also covers the strategic alliances observed within these key companies such as mergers and acquisitions, joint ventures, corporate and government deals, partnerships and agreements, and brand promotions and product launches.
Furthermore, the research study gives additional insights into the companies’ regional presence through extensive regional analysis. The regional analysis covers the key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The regional analysis segment covers details about the market share held by each region along with the prospective growth opportunities and revenue generation. The report also offers a projection of the growth rate for each region in the entirety of the forecast timeline. It also offers a country-wise analysis to impart a better understanding of the industry.
Thank you for reading our report. For further inquiries and information about the customization of this report, please get in touch with us. Our team will ensure you get the report well-suited for your needs.
submitted by swati_1510 to u/swati_1510 [link] [comments]


2020.12.04 17:34 swati_1510 Low Aromatic White Spirit Market Advancements, Growth Opportunity and Forecast 2020-2027

The current report on the Low Aromatic White Spirit Market provides a comprehensive assessment of the business vertical and offers a comprehensive overview of the industry along with its key segments. The study includes an accurate estimate of the current industry scenario along with the market size, market volume, and revenue garnered by the industry. The report delivers radical data about the competitive landscape of the Low Aromatic White Spirit industry and a thorough bifurcation of the regions where the Low Aromatic White Spirit market has established a significant footing. The report further estimates the market scenario in context with the COVID-19 pandemic. The report analyses the current market scenario along with the effects of the COVID-19 on the present and future scenario. The report also focuses on the key changes, progress, or hurdles due to the COVID-19 pandemic.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1681
Key Summary of Regional Analysis and Competitive Landscape:
The report offers a comprehensive overview of the competitive landscape of the Low Aromatic White Spirit industry. The competitive landscape includes extensive profiling and overview of prominent players of the Low Aromatic White Spirit industry. The report studies the following companies in detail: Royal Dutch Shell Plc, LyondellBasell Industries Holdings B.V, China Petroleum and Chemical Corporation, BASF SE, SK Global Chemical Co., Ltd, China National Petroleum Corporation, Reliance Industries Limited, ExxonMobil Corporation, Chinese Petroleum Corporation.
Radical Highlights of the Low Aromatic White Spirit Market Report:
The research report provides an accurate analysis of the product range, application spectrum, regional analysis, and competitive landscape of the Low Aromatic White Spirit industry.
The market is categorized on the basis of the types into
Toluene
Xylene
Ethylbenzene solvent
Based on application, the Low Aromatic White Spirit market is segmented into
Cleaning and Degreasing
Printing Inks
Adhesives
Paints and coatings
OthersThe report offers key details about the production volume and price analysis.
Moreover, it also offers radical information about growth prospects and patterns. It also provides extensive coverage of the product consumption of each application and product. The report also provides a pricing analysis and growth trends for the key segments of the market.
To know more about the report, click @ https://www.reportsanddata.com/report-detail/aromatic-solvents-market
Along with the basic information, the report also offers insights into marketing strategies readily adopted by the key manufacturers for the endorsement of their products. The report offers significant data pertaining to development trends and market position to offer deeper insights into targeted clients, brand promotions, and pricing analysis. The report also sheds light on the supply chains and the changes in the trends of the upstream raw materials and downstream distributors.
The report explains the market share and sales volume of each company, along with the key details of the operations of these companies. The report further offers extensive coverage of their product portfolio, business expansion plans, gross profit margins, revenue contribution, investment plans, and financial standings. The report also covers the strategic alliances observed within these key companies such as mergers and acquisitions, joint ventures, corporate and government deals, partnerships and agreements, and brand promotions and product launches.
Furthermore, the research study gives additional insights into the companies’ regional presence through extensive regional analysis. The regional analysis covers the key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The regional analysis segment covers details about the market share held by each region along with the prospective growth opportunities and revenue generation. The report also offers a projection of the growth rate for each region in the entirety of the forecast timeline. It also offers a country-wise analysis to impart a better understanding of the industry.
Thank you for reading our report. For further inquiries and information about the customization of this report, please get in touch with us. Our team will ensure you get the report well-suited for your needs.
submitted by swati_1510 to u/swati_1510 [link] [comments]


2020.12.04 16:12 dem0n0cracy Do Lower-Carbohydrate Diets Increase Total Energy Expenditure? An Updated and Reanalyzed Meta-Analysis of 29 Controlled-Feeding Studies - Lead Author David Ludwig - December 3, 2020

Do Lower-Carbohydrate Diets Increase Total Energy Expenditure? An Updated and Reanalyzed Meta-Analysis of 29 Controlled-Feeding Studies - Lead Author David Ludwig - December 3, 2020
https://academic.oup.com/jn/advance-article/doi/10.1093/jn/nxaa350/6020167

Do Lower-Carbohydrate Diets Increase Total Energy Expenditure? An Updated and Reanalyzed Meta-Analysis of 29 Controlled-Feeding Studies

David S Ludwig, Stephanie L Dickinson, Beate Henschel, Cara B Ebbeling, David B AllisonThe Journal of Nutrition, nxaa350, https://doi.org/10.1093/jn/nxaa350Published: 03 December 2020 Article history

ABSTRACT

Background
The effect of macronutrient composition on total energy expenditure (TEE) remains controversial, with divergent findings among studies. One source of heterogeneity may be study duration, as physiological adaptation to lower carbohydrate intake may require 2 to 3 wk.
Objective
We tested the hypothesis that the effects of carbohydrate [expressed as % of energy intake (EI)] on TEE vary with time.
Methods
The sample included trials from a previous meta-analysis and new trials identified in a PubMed search through 9 March 2020 comparing lower- and higher-carbohydrate diets, controlled for EI or body weight. Three reviewers independently extracted data and reconciled discrepancies. Effects on TEE were pooled using inverse-variance-weighted meta-analysis, with between-study heterogeneity assessed using the I2 statistic. Meta-regression was used to quantify the influence of study duration, dichotomized at 2.5 wk.
Results
The 29 trials ranged in duration from 1 to 140 d (median: 4 d) and included 617 participants. Difference in carbohydrate between intervention arms ranged from 8% to 77% EI (median: 30%). Compared with reported findings in the prior analysis (I2 = 32.2%), we found greater heterogeneity (I2 = 90.9% in the reanalysis, 81.6% in the updated analysis). Study duration modified the diet effect on TEE (P < 0.001). Among 23 shorter trials, TEE was reduced on lower-carbohydrate diets (−50.0 kcal/d; 95% CI: −77.4, −22.6 kcal/d) with substantial heterogeneity (I2 = 69.8). Among 6 longer trials, TEE was increased on low-carbohydrate diets (135.4 kcal/d; 95% CI: 72.0, 198.7 kcal/d) with low heterogeneity (I2 = 26.4). Expressed per 10% decrease in carbohydrate as %EI, the TEE effects in shorter and longer trials were −14.5 kcal/d and 50.4 kcal/d, respectively. Findings were materially unchanged in sensitivity analyses.
Conclusions
Lower-carbohydrate diets transiently reduce TEE, with a larger increase after ∼2.5 wk. These findings highlight the importance of longer trials to understand chronic macronutrient effects and suggest a mechanism whereby lower-carbohydrate diets may facilitate weight loss.
obesity, dietary carbohydrate, low-carbohydrate diet, dietary fat, carbohydrate-insulin model, energy expenditure, feeding study, metabolism
Diet Doctor wrote up a great explanation article which I recommend a clickthrough: https://www.dietdoctor.com/do-low-carb-eaters-burn-more-calories
TLDR:
According to senior author Dr. Ludwig:
We updated and reanalyzed a prior, high visibility meta-analysis by Kevin Hall, and found that – contrary to the original meta-analysis – total energy expenditure was significantly higher on low-carbohydrate vs. high-carbohydrate diets, after allowing a few weeks for metabolic adaptation to the change in macronutrients (a well-documented phenomenon).We believe this finding makes 3 major contributions to the science, in that the data:
  1. Provide the best available evidence to date that all calories are not metabolically alike
  2. Support a key prediction of the Carbohydrate-Insulin Mode
  3. Demonstrate the pitfalls of short diet studies (comprising the majority of published trials), a design issue of broad significance to the fields of obesity and nutrition.
This new meta-analysis is an essential contribution to the science of carbohydrate metabolism and should alter the way we interpret shorter low-carb diet studies.

Figure 2

Table 1

Table 2

Discussion

In this updated and reanalyzed meta-analysis, we found that heterogeneity among trials comparing the effect of lower- versus higher-carbohydrate diets on TEE is greater than previously reported (2), consistent with hypothesized effect modification by trial duration and/or additional factors. With control for duration and macronutrient difference, heterogeneity decreased substantially in our study. Among trials <2.5 wk, the lower-carbohydrate diets slightly reduced TEE, with reduced remaining heterogeneity. By contrast, among trials of >2.5 wk, the lower-carbohydrate diet substantially increased TEE—by ∼50 kcal/d for every 10% decrease in carbohydrate as %EI—with minimal residual heterogeneity. These results suggest that the shorter versus longer studies have examined different physiological states. The former consist of trials in which participants experienced varying degrees of metabolic adaptation to carbohydrate reduction; the latter consist of trials of sufficient duration to allow for adequate adaptation and to produce a consistent finding.
This finding supports a prediction of the carbohydrate-insulin model (4, 54–58) and suggests a mechanism whereby dietary carbohydrate reduction could aid in the prevention and treatment of obesity. According to this model, the high insulin-to-glucagon ratio with a diet high in glycemic load (mathematical product of glycemic index and carbohydrate amount) shifts the partitioning of metabolic fuels from oxidation in lean tissue to storage in adipose tissue. If the effects observed here persist over the long term, then reducing dietary carbohydrate intake by half from 60% of energy intake (a typical level for low-fat diets) would increase energy expenditure by ∼150 kcal/d, counterbalancing (if not compensated for by other factors) much of the secular increase in energy intake thought by some to underlie the obesity epidemic (59).
Consistent with our findings, short- versus long-term effects often differ in studies of dietary interventions (60). For instance, the rapid initial weight loss with very-low-calorie diets is not indicative of the effectiveness of these highly restrictive approaches for chronic obesity treatment. Thus, apart from mechanistic examination of the adaptive process per se, short-term studies comparing diets with differing macronutrient composition are likely to yield misleading estimates of long-term effects.
A main strength of this reanalysis is the ability to test a physiological hypothesis with adequate power, revealing an effect of macronutrients not apparent in the original analysis (2). We used a conservative statistical adjustment to examine how study duration affects outcome, and then conducted sensitivity analyses to examine plausible sources of bias. In addition, we have made the database with the trials publicly available to facilitate transparency and further examination.
Several limitations warrant consideration. First, many of the trials have low quality related to small size, lack of randomization, limited methodological detail (especially for the older studies), and other issues. Second, we cannot rule out the possibility of dietary nonadherence to the test diets. Participants in studies conducted at least partially outside of a metabolic ward could have underconsumed study foods or consumed foods off protocol. Dietary nonadherence would tend to inflate DLW estimation of TEE on a lower- versus higher-carbohydrate diet due to dependency of this method on estimated Food Quotient as a proxy for Respiratory Quotient. (This problem would not apply to WRC measurement of TEE, because Respiratory Quotient is determined directly.) Conversely, WRC may underestimate TEE due to suppression of nonresting energy expenditure (the component of TEE considered to be most involved in adaptive thermogenesis) (37). Reassuringly, we found no significant heterogeneity arising from the TEE measurement method after adjustment for study duration. Third, although ongoing adaptations beyond 3 wk cannot be excluded, we had insufficient power to test this possibility. To the extent that the longer studies included incompletely adapted participants, effect estimates could be underestimated. Fourth, we did not examine quantitative aspects of macronutrients that might affect insulin secretion or metabolism, such as glycemic index. According to preliminary data potentially consistent with the carbohydrate-insulin model, TEE by WRC decreased after 12 wk (by 136 kcal/d) with a diet high in sugar-sweetened beverages, whereas TEE either did not decrease or increased (by 127 kcal/d) with 2 comparison diets controlled for macronutrients that were high in either meat or fish, respectively (61). Dietary fatty acid type, specifically the relative amounts of saturated versus unsaturated fats, may also have metabolic effects of relevance to energy balance and adiposity (62). Fifth, only 1 trial examined effect modification by individual-level baseline biological characteristics (34), too few for meta-analysis. The carbohydrate-insulin model predicts that the largest increase in TEE with carbohydrate restriction will occur among individuals with the highest insulin secretion response to carbohydrate, defined as insulin concentration 30 min into a standard oral-glucose-tolerance test (63–66). Information about such subgroup susceptibility may inform a “personalized” approach to weight control, wherein a low-carbohydrate diet might be targeted to those most likely to benefit.
In view of the complexity of the physiological mechanisms and interindividual variability in response—potentially related to behavioral factors or biological factors such insulin secretion—high-quality studies with different designs will be necessary to further elucidate how macronutrients affect energy metabolism and fat storage, with attention to potentially susceptible subgroups, and translate findings to clinical interventions and public health messages. Important scientific and practical information could be obtained from trials that variously control energy intake (allowing body weight to change), control body weight (adjusting energy intake accordingly), or permit ad libitum food intake (controlling for confounding dietary and environmental factors when feasible). In addition, studies with participants habituated to a low-carbohydrate diet prior to randomization would also be of interest (the converse of most trials to date). An adequate trial duration will also be needed with this design, as consumption of a low-carbohydrate diet may protect for at least 1 mo against adverse effects of dietary carbohydrate on metabolism through persistent reduction in insulin secretion (65).
submitted by dem0n0cracy to ketoscience [link] [comments]


2020.12.04 14:22 niuz-bot Noi reguli pentru carantină în cazul persoanelor care intră în contact cu pacienți cu COVID sau care vin din zone cu riscul epidemiologic ridicat - [Actualitate][Coronavirus]

Comitetul Național pentru Situații de Urgență a stabilit vineri să fie exceptate de la măsura carantinării persoanele care au avut contact cu un pacient cu COVID-19 dacă se dovedește prin documente medicale că acestea au avut cel puțin un test pozitiv în ultimele 90 de zile anterioare producerii contactului și au trecut cel puțin 14 zile de la data primului test pozitiv și până la data contactului.
Citeste in continuare: https://www.hotnews.ro/stiri-coronavirus-24460079-noi-reguli-pentru-carantina-cazul-persoanelor-care-intra-contact-pacienti-covid-sau-care-vin-din-zone-riscul-epidemiologic-ridicat.htm
submitted by niuz-bot to niuz [link] [comments]


2020.12.04 12:54 niuz-bot VIDEO Orban: Cred că din 12 decembrie se va putea circula pe calea ferată Gara de Nord - Otopeni - [Politica]

Premierul Ludovic Orban a declarat vineri că cel mai probabil după data de 12 decembrie se va putea circula pe calea ferată Gara de Nord - Otopeni.
"În ceea ce priveşte calea ferată Gara de Nord - Otopeni, trebuie să se termine probele tehnice. Imediat după finalizarea prob...
Citeste in continuare: https://www.agerpres.ro/politica/2020/12/04/video-orban-cred-ca-din-12-decembrie-se-va-putea-circula-pe-calea-ferata-gara-de-nord-otopeni--621206
submitted by niuz-bot to niuz [link] [comments]


2020.12.04 11:31 RomeVisionClinic Occhio Secco: nuove possibili cure.

Occhio Secco: nuove possibili cure.
La sindrome dell’occhio secco (Dry Eye Syndrome, DES) è una patologia molto comune che infastidisce o delle volte persino invalida una consistente parte della popolazione che interessa prevalentemente quella femminile e con età avanzata.
Le sue cause sono molteplici (infiammazioni palpebrali o congiuntivali, utilizzo eccessivo o errato di lenti a contatto, assunzione di determinati farmaci o determinati colliri, carenza di vitamina A, agenti esterni come il vento e aria condizionata negli ambienti chiusi) e possono sostanzialmente manifestarsi con una ridotta produzione del film lacrimale, e/o un’eccessiva evaporazione dello stesso.

Come si riconosce?

https://preview.redd.it/nqdqluzjd5361.png?width=804&format=png&auto=webp&s=acc806fd904d8089cd7f86a47853d6ce4082b6c2
I pazienti con occhio secco riferiscono in maniera più o meno variabile una sensazione di corpo estraneo tipo “sabbiolina”, bruciore oculare, ipersensibilità alla luce e, curiosamente, un’eccessiva lacrimazione. Quest’ultima non è altro che una lacrimazione riflessa nella quale il film lacrimale prodotto risulta composto dalla sola componente acquosa. Un film lacrimale normale è costituito, invece, anche da una componente lipidica ed una mucinica che lo aiutano rispettivamente a ritardarne l’evaporazione e a rimanere ben adeso alla superficie oculare.
Per un’obiettiva diagnosi della patologia, il medico ha a disposizione diverse tecniche che si basano sulla valutazione qualitativa e quantitativa del film lacrimale.
Prima tra queste è il test di Schirmer, che misura il livello del film lacrimale tramite l’apposizione di due fascette di carta bibula appena internamente alla palpebra inferiore degli occhi. Queste vengono tenute per 5 minuti al termine dei quali si controlla quanto siano state imbibite dalle lacrime in ciascun occhio. Una fascetta bagnata per un valore uguale o inferiore a 5 millimetri indica una ipoproduzione di film lacrimale e quindi un occhio secco.
C’è poi il test del rosa bengala, colorante che, legandosi alle cellule epiteliali morte o degenerate della cornea, evidenzia abrasioni o desquamazioni della superficie oculare.
Simile a questo è il break up time (BUT), in cui l’operatore colora la superficie oculare con della fluoresceina e attende, guardandola alla lampada a fessura, che si creino delle discontinuità del colorante. Se il tempo intercorso è minore di 10 secondi, si è davanti ad un’anomalia del film lacrimale.
Tra i metodi più utilizzati, oltre a quelli precedentemente descritti, vi è oggi il test dell’osmolarità del film lacrimale (dato strettamente legato al grado di secchezza oculare), molto affidabile e realizzabile con un dispositivo chiamato Osmolarity TearLab.
Vi sono poi strumenti molto sofisticati e ad alta tecnologia come la Pentacam AXL che effettuando, tra le varie funzioni, l’esame della topografia corneale, riesce ad identificare le eventuali disomogeneità ed alterazioni della superficie oculare.

Come si cura?

Per improntare una terapia, il medico può adottare differenti strategie a seconda dell’alterazione presente e della componente del film lacrimale deficitaria, nonché della causa che ha determinato la secchezza oculare.
L’istillazione di lacrime artificiali continua ad essere il metodo più utilizzato: queste sono presenti in varie tipologie e con differenti caratteristiche tali da poter essere adattate alle diverse esigenze cliniche. Esse, infatti, possono avere sul film lacrimale un effetto ad esempio diluente, stabilizzante, volumizzante e sugli occhi stessi un effetto nutriente o antinfiammatorio. Le lacrime artificiali, presenti anche come creme o gel, ristabiliscono il più delle volte il comfort oculare desiderato e poiché il loro effetto risulta più o meno transitorio, possono essere istillate fino ad una goccia ogni ora.
Se tuttavia il medico rileva un’alterazione del film lacrimale di tipo quantitativo, il trattamento più semplice ed efficace che adotta è la chiusura dei puntini lacrimali inferiori e/o superiori attraverso l’utilizzo di piccolissimi tappi in collagene o silicone che bloccano il deflusso delle lacrime in maniera più o meno transitoria. In rari casi si può procedere con la chiusura definitiva dei puntini lacrimali attraverso un intervento chirurgico.
In altri casi, molto più estremi, si ricorre all’utilizzo di lenti a contatto terapeutiche che vengono applicate dai 2 ai 12 mesi con una funzione di mantenimento dell’idratazione della superficie oculare.

Il nuovo ruolo della neurostimolazione nelle patologie oculari.

Insieme alle cause inizialmente descritte, si è visto recentemente come anche le anomalie di tipo neurosensoriale giochino un ruolo eziologico nella patologia dell’occhio secco. Ecco perché oltre ai metodi terapeutici sopra detti, ancora oggi assolutamente efficaci e comunemente utilizzati in ambito clinico, cominciano a farsi strada nuove tecniche, tra cui quelle basate sulla neurostimolazione. Questa ha avuto, dagli anni ’50 ad oggi, applicazioni che hanno rivoluzionato la pratica clinica in diversi ambiti della medicina (si pensi al primo pacemaker impiantato nel 1958). Ciò che è stato evidenziato di recente, è che il trigemino, V nervo cranico formato da tre branche tra cui quella oftalmica, può diventare un target ideale per migliorare le condizioni dei pazienti con patologie oculari, data la sua posizione e il suo stretto rapporto con la superficie anteriore dell’occhio.

Come funziona?


https://preview.redd.it/ir3os0jud5361.png?width=758&format=png&auto=webp&s=12723b81c87b7e8550a5698d9a733a2fb08da6e7
La neurostimolazione crea dei segnali afferenti dalla branca oftalmica del nervo trigemino e attiva un percorso che termina nel suo nucleo, all’interno del tronco cerebrale, e in alcuni nuclei adiacenti. Ciò crea dunque dei riflessi efferenti che ritornano indietro, verso l’occhio. Sarebbe quindi possibile eccitare, attraverso la neurostimolazione, la branca oftalmica del trigemino creando le normali risposte nevralgiche che entrano nel nucleo del nervo. Il segnale efferente emulerà invece la normale stimolazione dell’unità funzionale lacrimale (LFU), gruppo di nervi rappresentante la componente-chiave della superficie oculare.
L’unità funzionale lacrimale, in particolare, innerva il meccanismo che produce la componente acquosa, le ghiandole di Meibomio che producono quella lipidica e le cellule caliciformi che secernono la componente mucinica. Quando questo intero percorso viene attivato dalla neurostimolazione, quindi, viene creato del film lacrimale composto nella sua interezza.
L’impianto di neurostimolazione recentemente creato è un dispositivo che il paziente stesso può controllare tenendolo in una sola mano e premendo un tasto che regola fino a 5 voltaggi differenti. E’ ideale per coloro che già assumono numerosi colliri per altre ragioni cliniche, ed ha la capacità di rappresentare una terapia che non sia né sistemica né topica.
E’ tuttavia indispensabile chiarire che questa rappresenterebbe una terapia adiuvante, ossia da intendersi complementare a quelle tradizionali sopra dette.
Per concludere, è importante che si capisca quanto importante sia curare la patologia dell’occhio secco, spesso sottovalutata o trascurata, perché oltre che dare un vantaggio tangibile soggettivamente, aumenterebbe l’idoneità del paziente ad eventuali interventi di chirurgia oculare, qualora egli dovesse averne bisogno nell’arco della sua vita.
submitted by RomeVisionClinic to u/RomeVisionClinic [link] [comments]


2020.12.04 11:15 setnom 21 de dezembro - Júpiter e Saturno vão parecer um "planeta duplo" no céu

21 de dezembro - Júpiter e Saturno vão parecer um
Não sei se têm olhado para o céu ultimamente ao anoitecer, mas o planeta Júpiter e Saturno têm estado a aproximar-se um do outro a partir do ponto de vista da Terra.
No dia 21 de dezembro vão estar tão perto um do outro que vão parecer um "planeta duplo" no céu (isto é, um único ponto brilhante à vista desarmada).
(retirado do Facebook - Grupo Astronomia - Portugal)
É fácil descobrir o planeta Júpiter. Tipo, uma hora depois do pôr-do-Sol (lá pelas 18 e qualquer coisa), virem-se para sudoeste (claro, com o céu desimpedido de árvores ou edifícios). O ponto mais brilhante nessa direção é o planeta Júpiter. O pontinho mais fraco, um pouco para cima e para a esquerda, é o planeta Saturno.
Com um qualquer smartphone também podem utilizar apps que facilitam descobrir a posição dos planetas (esta app, por exemplo) e dos outros astros.
Com o passar dos dias, vão notar que os dois planetas vão ficando mais perto um do outro, até ao máximo de dia 21.
Quem tiver acesso a uns binóculos ou um telescópio, poderá ver os dois planetas no mesmo campo de visão, exemplo:
O aspeto da conjunção de Júpiter e Saturno através de um telescópio de 8 polegadas com uma lente de 25mm.
Este evento (que no geral se dá o nome de "conjunção)") de dia 21/12, que coloca tão perto Júpiter e Saturno um o do outro a partir da nossa perspetiva, é muito raro. A última vez que aconteceu um assim tão "íntimo" foi na Idade Média (4 de março de 1226). Se for do vosso interesse, não deixem de o ir observando até ao dia 21, pois no futuro só haverá um semelhante no dia 15 de março de 2080. E depois dessa data, só lá para o ano 2400.
Aproveitem!
submitted by setnom to portugal [link] [comments]


2020.12.04 04:58 Neandertech Looking to continue successful Verizon "Connected Device" Sim Swapping for Data Only iPhone

6 years ago I did the following:
  1. ported my number to GV
  2. saw that the cheapest Verizon "line fee" was $5 / month for "connected devices"
  3. bought a Samsung EK-GC120 LTE enabled camera
  4. activated that device and sim as a "connected device" line on a 6GB / month "shared data" plan for $40 + $5 = $45 / month
  5. took the sim out and popped it into my iphone 5 / SE etc.
  6. returned the Samsung camera to the Verizon store.
  7. repeated process with wife's phone
I didn't think it would work but for the past 6 years we've had a Data-only iPhones that works great with VOIP and GV and iMessages, 6GB is enough for us, and pay ~$60 a month. VZ Online clearly shows devices as iPhones, but they've never given us any trouble.
Fast forward to now, got a new iPhone 12 mini and went to swap the sim from my old SE, no dice, "you need a 5G sim."
Got a 5G Sim off eBay, and bought another used Samsung EK-GC120 LTE to activate it, but it appears I can't activate the device online. Nervous about calling because I'm afraid they'll force me off my current plan, but if I can't use my iPhone 12 mini, might have to change anyway.
According to these old phonenews and cnet articles, VZ has said you are free to migrate your data sim, and the plan follows, but I'm guessing from lurking on here that trying to do that now would result in re-provisioning as "phone" and thus upping the line fee or something?
So if I want to stick with a data only plan (we're in NYC) is there a way to keep our plan and add a line with the iPhone 12 mini + 5G SIM, if I activate it with the Samsung Camera first and then swap?
IF NOT..
What are our best options for Data only plans? US mobile? Some AT&T Tablet plan or something?
Thanks all!
submitted by Neandertech to NoContract [link] [comments]


2020.12.04 03:21 altovaliriano Essa reportagem do Observer traz coisas interessantes de Game of Thrones que podem ter relação com House of the Dragon

A reportagem é essa: 'Game of Thrones' foi o sucesso mais feroz da HBO. Aqui como eles estão se virando sem o show.

Sobre Game of Thrones

Analisando o número de assinantes que deixaram a HBO nos últimos anos, a reportagem apresenta os seguintes números:
A falta de clareza dificulta determinar uma contagem exata, [...] mas a principal conclusão é que definitivamente houve uma queda nos assinantes gerais desde que Game of Thrones terminou. Mas como o terceiro maior serviço premium de SVOD no mercado interno, não é um desgaste tão grande quanto parece. Dados fornecidos pelo especialista em análise Sensor Tower para a Variety em junho de 2019 afirmaram que a HBO Now foi capaz de manter 84% da receita de assinantes recentes no primeiro ciclo de faturamento após o final de Game of Thrones. Perder 16% dos assinantes foi pior do que a queda de 7% após a 7ª temporada, mas também é uma grande melhoria em comparação ao êxodo de 40% após a 6ª temporada, concluída em 2016. Após a 5ª temporada, houve uma queda de 22%. É certo que o HBO Now (que ultrapassou 5 milhões de assinantes em sua última contagem oficial) representou apenas uma fatia do total de negócios da HBO. Desde então, o serviço foi incorporado pelo HBO Max. Mas vale a pena ter em mente o otimismo de retenção aí implícito. (tradução livre)
A informação é esta aí: a HBO teve uma grande perda de receita de assinantes com o fim da 6ª temporada. Eu não sei dizer se isso foi devido a outra série ou a Game of Thrones diretamente.
O curioso é que este seria um número plenamente explicável para 7ª temporada, pois a 8ª temporada só foi exibida 2 anos depois. Era lógico que os assinantes interessados exclusivamente em GoT cancelassem suas assinaturas e as refizessem em 2019.
Enfim, fica a dúvida.

Sobre House of the Dragon

Sobre o comportamento dos assinantes de serviços de streaming em geral, o Observer destaca o seguinte:
A assinatura média entre os principais serviços de streaming dura 31 meses, de acordo com dados compartilhados com a NBC News no ano passado pela Parks Associates. Se forem precisos, eles sugerem que, embora a HBO tradicional tenha sofrido uma recessão após a conclusão de Game of Thrones, aqueles [serviços de straming] que converteram assinantes não-lineares da HBO provavelmente permanecerão na cadeia alimentar por mais tempo. Resumindo: os assinantes totais caíram nos últimos 18 meses, mas não ao nível crítico que muitos esperavam, já que a HBO continua forte no mercado.
Game of Thrones terminou em 19/05/2019. Se adicionarmos 31 meses a essa data, resultaria em 19/12/2021, ou seja, alguns dias antes do começo de 2022. A estreia de House of the Dragon está prevista para 2022.
Ou seja, fica parecendo que a HBO está tocando a produção de HotD com base no tempo médio em que conseguem segurar os assinantes que entraram no serviço no final da 8ª temporada de GoT.
Ou então é apenas coincidência.
O que vocês acham?
submitted by altovaliriano to Valiria [link] [comments]


2020.12.04 01:24 IHateTypingInBoxes IEM Measurement Tools - Audix TM2 and SLS-Audio MiEMi

IEM Measurement Tools - Audix TM2 and SLS-Audio MiEMi
I spent some time today playing with both of these tools designed to allow you to measure In Ear Monitors with an audio analyzer. In this post I'll be discussing the Audix TM2 and the SLS-Audio MiEMi.
Here are my comments on both - please note, this is not intended to be an exhaustive or official review, just my initial impressions.

MiEMi

This unit is an aluminum coupler designed specifically for use with the iSemCon EMX-7150 measurement microphone (which works out well because the EMX-7150 is my go-to for measurement work). There is also a less expensive, 3D-printed version of the coupler that is sold to fit a variety of other mic sizes and is, according to the website, less accurate. The rubber coupler is easily replaceable. You fold the coupler in on itself and then press the IEM in.

SLS-Audio MiEMi

Audix TM2

This unit is a standalone measurement coupler, which means its measurement mic is built into the unit itself. You connect an XLR cable to the base and engage phantom power on your interface.

Audix TM2
It ships with a few different adapters - "small" and "large" for measuring the two standard sizes of IEMs without the eartips attached, a "custom" adapter for measuring with the eartips attached, and a fourth that fits to the standard half-inch diameter acoustic calibrator for calibrating the TM2 for SPL. These come in a zip case that also holds the TM2.

https://preview.redd.it/4160ar8ix1361.png?width=1349&format=png&auto=webp&s=4ca0cf79a69ff95b2097310ed30f8813bb53f3e1
The TM2 also ships with a printout of the unit's frequency response deviation from the benchmark unit, done with an Audio Precision analyzer, and a USB keydrive containing the corresponding correction file. The deviations were all less than +/- 1 dB below 8 kHz (above 8 kHz, IEM measurements get really tricky due to coupler resonances and insertion variance, so I'm not usually paying a ton of attention to the top octave.). Here's the correction curve from the particular unit I tested:

https://preview.redd.it/78i9bg4ly1361.png?width=1585&format=png&auto=webp&s=9a648a956fd90bb8f8772c3121057381d2cb4014

Testing...Testing...heyheyYahTssTss

Okay, here's what you all came to see, I'm sure. With both of these units, you are setting the coupler up as your Measurement input to the analyzer and using a loopback for the reference signal, just as you would with a typical dual channel measurement setup. The only difference is that we also need to drive the IEMs themselves via the IO's headphone out. Honestly, it's probably not a terrible idea to do an idiot-check validation transfer function between the Line level outs and the Headphone outs on your interface and make sure that comes up flat before you do more testing.
My two concerns with devices like this are accuracy (how close is this result to the actual response?) and precision (do I get the same answer every time?). This is where some of the guerilla DIY IEM test rigs fall flat. I will answer both questions at once. The image below shows the left side of my Mackie MP-240 IEMs (which are fantastic for the price!) measured six times: three times each with each rig. We see that not only do we get the same answer each time, but both systems seem to agree. (1/12 oct smoothing)

Six measurements of the same IEM: three with each system
The trick with these is that even small variances in insertion can create significant differences at the frequency extremes (below 100 Hz and above 8 kHz or so). The MiEMi is definitely more fussy in this regard, and it took a little practice to be able to get repeated measurements. The Audix unit is a lot more stable and seems to have a more robust grip on the IEM. It can help to provide some strain relief on the cable, or to rest a thumb on the IEM to keep it in place during the measurement, but you have to be really careful not to make any motions that would bump the mic. The TM2 is a lot more forgiving in this aspect.
That being said, I'm really interested in the broad strokes here: does L match R? Do your IEMs measure the same tonight as they did last week? Much as with measuring a PA system, this is about the forest, not the trees.
As an interesting aside, it seems that a lot of IEMs have a HF problem. Here we see my Mackie MP-240 in blue and Shure SE-315 in pink, normalized to the mid-band (500 Hz).

https://preview.redd.it/4w0nhiw582361.png?width=1618&format=png&auto=webp&s=fed956b4676a285b346684c4ec2150fd646d77c0
The Shure HF takes a bump up above 1 kHz and then falls off a cliff completely above 4 kHz, which seems to be a common trend. The SLS website has measurements of some other common IEM units and a lot of them exhibit the same trait.
(Heads up - their screenshots are magnitude on top, phase on the bottom, the opposite of what appears here. Many of them also use heavy smoothing and a greatly compressed vertical scale of +/- 35 dB or even more in some cases, which can make the responses seem flatter than they really are. Just some things to be aware of when browsing the data on your own.)
My subjective perception of the SE-315's is that they had a little too much going on in the hi-mid band and it's interesting to see that borne out in the data.

SPL Calibration

Another interesting (and dare I say very important) aspect of this is the ability to calibrate the TM2 for SPL and have an idea of what sort of sound exposure our artists are enduring (provided, of course, we control for variables such as the pack level knob, etc. I have found that my artists tend to set their pack levels once and then not touch them again, so I could in theory collect the packs after the show while still on, and measure them at that point to get an accurate idea).
This is cool stuff - for purposes of sound exposure, we're interested in average A weighted levels (LAeq), or looking at the NIOSH dose directly as a %:

IEM SPL meter bridge in Smaart. Exposure N is NIOSH Recommended Exposure Limit in percent dose.
One particular concern for me would be an artist who takes out one side of their IEMs, which means turning up the pack much more to get the same perceived loudness, and that extra 6 - 9 dB means 4 to 8 times the noise exposure, not to mention what's coming in the other ear. So the ability to quantify the risk in these types of situations is a pretty cool and very welcome thing.
SPL calibration is the other area where the MiEMi is probably not the best tool for the application, as you're calibrating the mic for SPL and then fitting it with the coupler, which changes the equation, versus the TM2, where you calibrate the coupler directly. The SPL values I measured with the MiEMi were lower by 4 - 6 dB than the calibrated TM2 values depending on the IEM I was measuring, and that's far too large of a window if the goal is measuring exposure. (Accuracy is super important when it comes to exposure, which I won't dive into here, but feel free to ask if interested.)

Conclusions

I think these are both great tools and welcome additions to a monitor engineer's toolkit. For consistency and spot checks, they will both do the job well once you get the hang of consistent and well-sealed insertions (giggity?). Remember that the TM2 is a self-contained unit whereas with the MiEMi you'll need an EMX-7150 microphone as well. These are pretty popular in the measurement world, so you might already have one, and they're also a solid investment - SLS sells the coupler and the mic as a bundle. The additional accuracy gained by the TM2 correction file is probably not super important in most circumstances, but the accurate SPL calibration is a big selling point in my opinion. That's my two cents, hopefully it's helpful to anyone considering investing in one of these tools.
I'm happy to answer any questions, although of course I recommend going right to the source for the best information. For Audix, that's via email at [[email protected]](mailto:[email protected]). If you're in the US and interested in MiEMi, you'll want to reach out to Dennie Miller ( u/_MillerAi) at Miller Audio Industries, he is the man.
submitted by IHateTypingInBoxes to livesound [link] [comments]


2020.12.03 22:34 TheFancyNerd Properly Installing Skyrim With A Proper Directory And How To Install SKSE64

Now that you have properly set up what you should do before installing the game it's time to actually install the actual game.
the #1 thing with modding Skyrim is NEVER installing the game or steam for that matter in your Program files or (x86) program files this may prevent you from using tools in the future such as Xedit and Zedit so to practice proper modding techniques it is recommended you install steam outside of this directory.
Step 1)
(for people who don't have steam installed already all you need to do is create a folder somewhere else where you want your steam directory and go through the steam installer and when you get to the selection called 'Destination Folder' click browse and find the folder that you created and hit select folder, hit install, then hit 'finish' and run steam then install your games as desired and skip to step 2)
if you already have your library made and set up then this is how you move it.
and download steam. go through the installation and when you get to the step in the launcher called 'Destination Folder' click browse. Navigate to the folder that you created and hit select folder then hit install, then hit finish. Run steam and log in.
you are now done and can continue if you want to watch a video I link this one right here to assist you
https://www.youtube.com/watch?v=4FEc2DUIWQU

Step 2)
now that you have steam and Skyrim properly set up you there needs to be a few alterations made to the Skyrim control panel
1) go into the Nvidia control panel
2) click on manage 3D settings
3) go to the tab that says 'program' settings and in the 'select a program to customize' and choose 'The Elder Scrolls V: Skyrim Special Edition'
now in the box change the settings as follows ( this is settings running Skyrim on a GTX 1080 so adjust settings as you please)

Image Sharpening: Off
Ambient Occlusion: Off
Anisotropic filtering: Application Controlled
Antialiasing - FXAA: Off
Antialiasing - Gamma correction: On
Antialiasing - Mode: Application Controlled
Antialiasing - Setting: Application-Controlled
Antialiasing - Transparency: Off
CUDA - GPUs: All
Low Latency Mode: Off
Max Frame Rate: Off
Multi-Frame Sampled AA (MFAA): Off
OpenGL rendering GPU: Auto-select
Power management mode: Prefer maximum performance
Shader Cache: On
Texture Filtering - Anisotropic Sample: Off
Texture Filtering - Negative LOD: Allow
Texture Filtering - Quality: Quality
Texture Filtering - Trillnear OptimizationTrilinear: On
Threaded OptomizaOptimizationtion: Auto
Triple buffering: ON
Verticle sync: ON
Virtual Reality pre-rendered frames: 1

Step 3
Now that you have Skyrim installed correctly it is time to install SKSE64 which you can find here
http://skse.silverlock.org/download/archive/

I have had some issues using 2.0.0.19 and have opted for this guide to using 2.0.0.17 as there isn't much of a difference and it seems that compatibility is much better so until further notice I recommend using the .17 build.






Now you have SKSE64 installed you can test the game by running the skse64_loader.exe to launch the game.

I don't want to overload the user so the next tutorial is how to use mod organizer, what mods to get, proper load order techniques and how to use applications like Xedit or running Skse through Modorganizer
enjoy and good luck modding :) and any suggestions please let me know in the comments
submitted by TheFancyNerd to SkyrimSEModdingHelp [link] [comments]


2020.12.03 22:12 0toHeroInvesting Prizer vaccine supply cut wipes out S&P 500 gains, stimulus optimism

Pfizer (PFE -2.1%) expects to ship only half of the COVID-19 vaccine doses this year that it originally planned due to supply chain obstacles, a near-term problem considering its ultra-cold storage requirement of minus 70 degrees Celsius. A company spokesperson stated that the headwinds were due to a later-than-expected data readout from the pivotal trial and challenges scaling up the raw material supply chain.
Pfizer Inc. expects to ship half of the Covid-19 vaccines it originally planned for this year because of supply-chain problems, but still expects to roll out more than a billion doses in 2021.“Scaling up the raw material supply chain took longer than expected,” a company spokeswoman said. “And it’s important to highlight that the outcome of the clinical trial was somewhat later than the initial projection.”
Pfizer and Germany-based partner BioNTech SE had hoped to roll out 100 million vaccines world-wide by the end of this year, a plan that has now been reduced to 50 million. The U.K. on Wednesday granted emergency-use authorization for the vaccine, becoming the first Western country to start administering doses.
The two-shot vaccine also is being reviewed by the Food and Drug Administration in the U.S., where a similar authorization could come later this month and a rollout before the end of the year. The U.S. regulator also is considering a vaccine developed by Cambridge, Mass.-based Moderna Inc. that could begin shipping before Christmas.The doses are among an array of vaccines that have been developed this year as the coronavirus pandemic has raged across much of the world. Authorities estimate nearly 1.5 million people world-wide have died from the virus, including 273,836 in the U.S. as of Dec. 2.“We were late,” said a person directly involved in the development of the Pfizer vaccine. “Some early batches of the raw materials failed to meet the standards. We fixed it, but ran out of time to meet this year’s projected shipments.”Pfizer sources its raw materials from providers in the U.S. and Europe. Scaling up production of these components proved challenging last month as the company awaited the results of its trials, which came in to be 95% effective and well-tolerated in a 44,000-subject trial.Pfizer wouldn’t say where shortfalls over ingredients arose as it ramped up production. Vaccines typically contain materials from suppliers that can include antivirus agents, antiseptic liquids, sterile water and elements of the DNA of the virus itself that won’t cause serious symptoms but trigger the immune system to make antibodies.In a typical vaccination campaign, pharmaceutical companies would wait until their product is approved before buying raw materials, establishing manufacturing lines and setting up supply chains to ship a vaccine. Pfizer has never manufactured a vaccine with technology that uses mRNA, the molecular couriers that carry genetic instructions to cells in the human body, so it has had to scale up production capacity even as research was still under way.“For this one, everything happened simultaneously,” the person familiar with the Pfizer development said. “We started setting up the supply chain in March, while the vaccine was still being developed. That’s totally unprecedented.”Pfizer and BioNtech are now on track to roll out 1.3 billion vaccines in 2021 and the 50 million dose shortfall this year will be covered as production ramps up.The company is setting up what it has described as its biggest ever vaccination campaign through two final assembly and distribution centers in Kalamazoo, Mich., and Puurs, Belgium, which will handle the European supply.The U.K. authorization marks a milestone in the effort to develop a promising new vaccine technology into a widely available shot in record time.The U.K. ordered 40 million Pfizer doses, enough to vaccinate 20 million people. The government said in November that it could get up to 10 million doses this year, but the expectation now is that four to five million vaccines will be shipped.
U.K. Health Secretary Matt Hancock said the shots will be rolled out as quickly as they can be made at Pfizer’s Belgium plant. Some 800,000 are due in the coming days and “several millions” throughout December, he said.
The U.S. government has placed an initial order for 100 million doses of the Pfizer vaccine, with the option to purchase 500 million additional doses.The EU ordered 200 million doses with an option for another 100 million. Japan ordered 120 million doses, and countries in South America and in the Asia-Pacific region also have placed significant orders.
Source: SA & WSJ
submitted by 0toHeroInvesting to u/0toHeroInvesting [link] [comments]


2020.12.03 22:09 0toHeroInvesting Prizer vaccine supply cut wipes out S&P 500 gains, stimulus optimism

Pfizer (PFE -2.1%) expects to ship only half of the COVID-19 vaccine doses this year that it originally planned due to supply chain obstacles, a near-term problem considering its ultra-cold storage requirement of minus 70 degrees Celsius. A company spokesperson stated that the headwinds were due to a later-than-expected data readout from the pivotal trial and challenges scaling up the raw material supply chain.
Pfizer Inc. expects to ship half of the Covid-19 vaccines it originally planned for this year because of supply-chain problems, but still expects to roll out more than a billion doses in 2021.“Scaling up the raw material supply chain took longer than expected,” a company spokeswoman said. “And it’s important to highlight that the outcome of the clinical trial was somewhat later than the initial projection.”

Pfizer and Germany-based partner BioNTech SE had hoped to roll out 100 million vaccines world-wide by the end of this year, a plan that has now been reduced to 50 million. The U.K. on Wednesday granted emergency-use authorization for the vaccine, becoming the first Western country to start administering doses.

The two-shot vaccine also is being reviewed by the Food and Drug Administration in the U.S., where a similar authorization could come later this month and a rollout before the end of the year. The U.S. regulator also is considering a vaccine developed by Cambridge, Mass.-based Moderna Inc. that could begin shipping before Christmas.The doses are among an array of vaccines that have been developed this year as the coronavirus pandemic has raged across much of the world. Authorities estimate nearly 1.5 million people world-wide have died from the virus, including 273,836 in the U.S. as of Dec. 2.“We were late,” said a person directly involved in the development of the Pfizer vaccine. “Some early batches of the raw materials failed to meet the standards. We fixed it, but ran out of time to meet this year’s projected shipments.”Pfizer sources its raw materials from providers in the U.S. and Europe. Scaling up production of these components proved challenging last month as the company awaited the results of its trials, which came in to be 95% effective and well-tolerated in a 44,000-subject trial.Pfizer wouldn’t say where shortfalls over ingredients arose as it ramped up production. Vaccines typically contain materials from suppliers that can include antivirus agents, antiseptic liquids, sterile water and elements of the DNA of the virus itself that won’t cause serious symptoms but trigger the immune system to make antibodies.In a typical vaccination campaign, pharmaceutical companies would wait until their product is approved before buying raw materials, establishing manufacturing lines and setting up supply chains to ship a vaccine. Pfizer has never manufactured a vaccine with technology that uses mRNA, the molecular couriers that carry genetic instructions to cells in the human body, so it has had to scale up production capacity even as research was still under way.“For this one, everything happened simultaneously,” the person familiar with the Pfizer development said. “We started setting up the supply chain in March, while the vaccine was still being developed. That’s totally unprecedented.”Pfizer and BioNtech are now on track to roll out 1.3 billion vaccines in 2021 and the 50 million dose shortfall this year will be covered as production ramps up.The company is setting up what it has described as its biggest ever vaccination campaign through two final assembly and distribution centers in Kalamazoo, Mich., and Puurs, Belgium, which will handle the European supply.The U.K. authorization marks a milestone in the effort to develop a promising new vaccine technology into a widely available shot in record time.The U.K. ordered 40 million Pfizer doses, enough to vaccinate 20 million people. The government said in November that it could get up to 10 million doses this year, but the expectation now is that four to five million vaccines will be shipped.

U.K. Health Secretary Matt Hancock said the shots will be rolled out as quickly as they can be made at Pfizer’s Belgium plant. Some 800,000 are due in the coming days and “several millions” throughout December, he said.

The U.S. government has placed an initial order for 100 million doses of the Pfizer vaccine, with the option to purchase 500 million additional doses.The EU ordered 200 million doses with an option for another 100 million. Japan ordered 120 million doses, and countries in South America and in the Asia-Pacific region also have placed significant orders.
Source: SA & WSJ
submitted by 0toHeroInvesting to stocks [link] [comments]


2020.12.03 22:09 0toHeroInvesting Prizer vaccine supply cut wipes out S&P 500 gains, stimulus optimism

Pfizer (PFE -2.1%) expects to ship only half of the COVID-19 vaccine doses this year that it originally planned due to supply chain obstacles, a near-term problem considering its ultra-cold storage requirement of minus 70 degrees Celsius. A company spokesperson stated that the headwinds were due to a later-than-expected data readout from the pivotal trial and challenges scaling up the raw material supply chain.
“Scaling up the raw material supply chain took longer than expected,” a company spokeswoman said. “And it’s important to highlight that the outcome of the clinical trial was somewhat later than the initial projection.”

Pfizer and Germany-based partner BioNTech SE had hoped to roll out 100 million vaccines world-wide by the end of this year, a plan that has now been reduced to 50 million. The U.K. on Wednesday granted emergency-use authorization for the vaccine, becoming the first Western country to start administering doses.

The two-shot vaccine also is being reviewed by the Food and Drug Administration in the U.S., where a similar authorization could come later this month and a rollout before the end of the year. The U.S. regulator also is considering a vaccine developed by Cambridge, Mass.-based Moderna Inc. that could begin shipping before Christmas.
The doses are among an array of vaccines that have been developed this year as the coronavirus pandemic has raged across much of the world. Authorities estimate nearly 1.5 million people world-wide have died from the virus, including 273,836 in the U.S. as of Dec. 2.
“We were late,” said a person directly involved in the development of the Pfizer vaccine. “Some early batches of the raw materials failed to meet the standards. We fixed it, but ran out of time to meet this year’s projected shipments.”
Pfizer sources its raw materials from providers in the U.S. and Europe. Scaling up production of these components proved challenging last month as the company awaited the results of its trials, which came in to be 95% effective and well-tolerated in a 44,000-subject trial.
Pfizer wouldn’t say where shortfalls over ingredients arose as it ramped up production. Vaccines typically contain materials from suppliers that can include antivirus agents, antiseptic liquids, sterile water and elements of the DNA of the virus itself that won’t cause serious symptoms but trigger the immune system to make antibodies.
In a typical vaccination campaign, pharmaceutical companies would wait until their product is approved before buying raw materials, establishing manufacturing lines and setting up supply chains to ship a vaccine. Pfizer has never manufactured a vaccine with technology that uses mRNA, the molecular couriers that carry genetic instructions to cells in the human body, so it has had to scale up production capacity even as research was still under way.
“For this one, everything happened simultaneously,” the person familiar with the Pfizer development said. “We started setting up the supply chain in March, while the vaccine was still being developed. That’s totally unprecedented.”
Pfizer and BioNtech are now on track to roll out 1.3 billion vaccines in 2021 and the 50 million dose shortfall this year will be covered as production ramps up.
The company is setting up what it has described as its biggest ever vaccination campaign through two final assembly and distribution centers in Kalamazoo, Mich., and Puurs, Belgium, which will handle the European supply.
The U.K. authorization marks a milestone in the effort to develop a promising new vaccine technology into a widely available shot in record time.
The U.K. ordered 40 million Pfizer doses, enough to vaccinate 20 million people. The government said in November that it could get up to 10 million doses this year, but the expectation now is that four to five million vaccines will be shipped.

U.K. Health Secretary Matt Hancock said the shots will be rolled out as quickly as they can be made at Pfizer’s Belgium plant. Some 800,000 are due in the coming days and “several millions” throughout December, he said.

The U.S. government has placed an initial order for 100 million doses of the Pfizer vaccine, with the option to purchase 500 million additional doses.
The EU ordered 200 million doses with an option for another 100 million. Japan ordered 120 million doses, and countries in South America and in the Asia-Pacific region also have placed significant orders.
Source: SA & WSJ
submitted by 0toHeroInvesting to StockMarket [link] [comments]


2020.12.03 19:12 Fimfarchive Fimfarchive 20201201 released! All stories on Fimfiction in a single archive.

Thirtieth release with 192346 stories.
Fimfarchive is a project which aims to release all stories available on Fimfiction, together with their metadata, as a single archive. The archive is organized by author and could be used for backup, offline reading, or data mining.
A new version will be released each season via BitTorrent, approximately once every three months. When suitable, an xdelta3 patch will also be provided for users who do not wish to redownload unchanged stories.
Note that the archive contains a large number of files. Unzipping it to your file system may not be necessary if the archive is to be used together with some application. If you are a developer, reading directly from the ZIP-file may be preferable.
The complete archive.
The xdelta3 patch.
This is not an official Fimfiction project!
Do not contact Fimfiction staff for support regarding this archive.
Post questions as a comment or private message to this account instead!
More Information
See the README file or my submission history for more information.
Thanks to hawthornbunny for looking through the archive prior to this release.
Merry Floofmas!
http://www.fimfiction.net/useFimfarchive
submitted by Fimfarchive to mylittlepony [link] [comments]


2020.12.03 16:35 magicomplex [PCQ/AMA] Eu faço a internet funcionar, me pergunte qualquer coisa. (2020)

Como ainda percebo que muitos internautas acham que nós que trabalhamos na área só queremos enganá-los, que existe traffic shaping, que não entregamos a banda contratada e ficamos gargalhando de vocês usuários, faço mais um AMA aqui.
Por conta do meu primeiro AMA (recomendo a leitura), vi que havia interesse suficiente aqui no Reddit sobre o assunto e criei um sub especializado, o InternetBrasil. Como gostei da brincadeira, também recomendo a leitura do meu segundo AMA com mais perguntas fascinantes que outros caros redditors me fizeram. Nesse segundo AMA minha identidade foi validada pelos moderadores daqui do brasil.
Antes que confundam, não sou o técnico que vai na sua casa trocar o modem nem um daqueles (heróis, diga-se de passagem) que sobem nos postes e dirigem Fiat Uno com escada presa no teto.
A internet é composta pela interconexão de várias redes (daí o nome dela). Eu faço essa interconexão entre as empresas, os provedores (principalmente) e os países. A empresa para qual trabalho é conhecida apenas em nosso ramo e não pelo consumidor final. O típico cliente que atendo é o dono/diretor de provedores de internet, data centers, donos de conteúdo (EaD, produtoras de vídeo, plataformas online) ou grandes consumidores de internet que já compram no atacado (ex.: universidades, petroquímicas). O produto que lido é além do link dedicado de internet, chama-se no mercado IP Transit.
Então entre o provedor que coloca o modem na sua casa e o site de vídeo de gatinhos de sua preferência está o nicho onde atuo. Pergunte-me qualquer coisa!
Links úteis:
submitted by magicomplex to brasil [link] [comments]


2020.12.03 14:44 niuz-bot O comună din judeţul Dolj se alătură localităţilor cu platforme pentru gunoiul de grajd, finanţate de Ministerul Mediului - [Mediu]

Comuna Bistreţ din judeţul Dolj se alătură localităţilor cu platforme pentru gunoiul de grajd, finanţate de Ministerul Mediului, Apelor şi Pădurilor (MMAP), potrivit unui comunicat remis joi AGERPRES.
"În data de 2 decembrie 2020, a fost semnată recepţia la terminarea lucră...
Citeste in continuare: https://www.agerpres.ro/mediu/2020/12/03/o-comuna-din-judetul-dolj-se-alatura-localitatilor-cu-platforme-pentru-gunoiul-de-grajd-finantate-de-ministerul-mediului--620524
submitted by niuz-bot to niuz [link] [comments]


2020.12.03 08:47 TDex96 Every time i got bad network connection

Hi guys! So, i use this service about last 3-4 months. Sometimes i got bad network message until the game session, but nothing bad because i played lazy games and i don't care. BUT NOW. NOW, when i want to play R6, CS:GO or ETS2, every 5, 6 minutes i got spooty connection warning message with yellow and red words and i can't play normally. I tried different Server Location(EU Central2,3,4, EU SE) and different streaming quality also. Data Saver and custom with 2 gb network hourly traffic. I also check with the Test Network function and everything was good. This is my actual network speed: https://www.speedtest.net/result/10520900349.png I play on MacBook Pro 13 2017. Can you help me guys, shomehow?
submitted by TDex96 to GeForceNOW [link] [comments]